These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2832178)

  • 21. Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung.
    Warner-Efrati E; Sulkes A; Weshler Z; Peretz T; Ben-Yosef R; Catane R; Biran S
    Isr J Med Sci; 1988; 24(9-10):593-8. PubMed ID: 2849598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide versus methotrexate in small cell bronchial carcinoma. A randomized study of two types of four-drug chemotherapy regimens.
    Nõu E; Lamberg K; Brodin O
    Acta Oncol; 1992; 31(8):853-60. PubMed ID: 1337833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer.
    Nikkanen V; Liippo K; Ojala A; Jakobsson M; Järvinen M; Paloheimo S; Nordman E
    Acta Oncol; 1990; 29(4):421-4. PubMed ID: 2167702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.
    Johnson DH; Bass D; Einhorn LH; Crawford J; Perez CA; Bartolucci A; Omura GA; Greco FA
    J Clin Oncol; 1993 Jul; 11(7):1223-9. PubMed ID: 8391064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
    Livingston RB; Mira JG; Chen TT; McGavran M; Costanzi JJ; Samson M
    J Clin Oncol; 1984 Jun; 2(6):585-90. PubMed ID: 6327927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
    Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
    J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial.
    Coy P; Hodson I; Payne DG; Evans WK; Feld R; MacDonald AS; Osoba D; Pater JL
    Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):219-26. PubMed ID: 2828289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
    Brooks BJ; Seifter EJ; Walsh TE; Lichter AS; Bunn PA; Zabell A; Johnston-Early A; Edison M; Makuch RW; Cohen MH
    J Clin Oncol; 1986 Feb; 4(2):200-9. PubMed ID: 3003259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
    Ohnoshi T; Ueoka H; Numata T; Kawahara S; Nishii K; Yonei T; Mima Y; Horiguchi T; Kiura K; Moritaka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):190-6. PubMed ID: 2162437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Global approach to the treatment of small cell bronchial cancers].
    Lebeau B
    Bull Cancer; 1987; 74(5):555-8. PubMed ID: 2825856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality treatment of short duration in small cell lung cancer.
    Bakker W; Nijhuis-Heddes JM; van Oosterom AT; Noordijk EM; Hermans J; Dijkman JH
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1033-7. PubMed ID: 6088248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.